Nexium Buyers Push 1st Circ. For New Pay-For-Delay Trial
Wholesalers, pharmacies and other Nexium buyers asked the First Circuit on Friday for another shot to prove their case that AstraZeneca and Ranbaxy inked an illegal pay-for-delay deal for the heartburn...To view the full article, register now.
Already a subscriber? Click here to view full article